The risk and outcomes of pneumonia in patients on inhaled corticosteroids

Oriol Sibila, Natalia Soto-Gomez, Marcos I. Restrepo

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Corticosteroids are frequently prescribed anti-inflammatory medications. Inhaled corticosteroids (ICS) are indicated for Chronic Obstructive Pulmonary Disease (COPD) and asthma. ICS are associated with a decrease in exacerbations and improved quality of life in COPD, however multiple studies have linked the chronic use of ICSs with an increased risk of developing pneumonia, though the effect on mortality is unclear. We review the association of ICS with the risk of pneumonia and the implications on clinical outcomes.

Original languageEnglish (US)
Pages (from-to)130-136
Number of pages7
JournalPulmonary Pharmacology and Therapeutics
StatePublished - Jun 1 2015


  • Chronic obstructive pulmonary disease
  • Inhaled corticosteroids
  • Pneumonia

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Biochemistry, medical
  • Pharmacology (medical)


Dive into the research topics of 'The risk and outcomes of pneumonia in patients on inhaled corticosteroids'. Together they form a unique fingerprint.

Cite this